IRESS Limited Overview
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Employees (headcount, approx.) | 2,250 | 1,500 | 1,153 |
Notes: The FY2023 value is implied from April 2023 commentary and is not a reported year-end figure. The FY2024 value is approximate, from the FY24 results call summary. The FY2025 value is reported [AR25].
Iress is a mid-cap Australian vertical software vendor whose products sit inside the core workflows of regulated financial-services firms. The group has emerged from a three-year portfolio reset (2023–2025) as a focused business with two franchises. The first is Wealth: Xplan financial-advice software in Australia/New Zealand and the UK, plus UK protection and retirement "Sourcing" comparison platforms. The second is Global Trading & Market Data (GTMD): order management, trading terminals, FIX connectivity and market data for sell-side and retail brokers in Australia, South Africa and Canada.
Continuing revenue is roughly A$500m with about 95% recurring [1H26R]. Management is now pivoting from divestment and cost-out to product modernisation, AI embedding and margin expansion, targeting a 25% Cash EBITDA margin exit run-rate by end-2026. The investment debate turns on whether Iress's entrenched, high-switching-cost incumbency can be converted into growth after a failed 2025 private-equity process and a muted revenue outlook.
Company's own description (paraphrased from FY25 Annual Report)
The 2025 Annual Report describes Iress as a technology company that designs and develops software and services for the financial-services industry, operating across Asia-Pacific, the United Kingdom & Europe, South Africa and North America [AR25]. Its stated purpose is to use technology to enable a smarter financial system that delivers more for everyone.
The report frames the client base as ranging from small retail firms to large institutions. It positions Iress software as essential infrastructure at the centre of clients' operations. In the FY25 letter, the Chair and CEO describe 2025 as the year Iress left its "transformation era" and became a simpler business focused on two enterprise software franchises: Wealth, and Trading & Market Data [AR25].
The Annual Report organises the offering into four software families [AR25]:
-
Financial advice: an integrated advice platform covering client management, business automation, portfolio data, research, planning tools, scaled-advice journeys, digital client solutions, analytics, regulatory obligations management, and revenue and payments management. Clients are institutional and independent advisory firms and superannuation funds.
-
Trading & market data: trading interfaces, order and execution management, smart order routing, FIX services, portfolio management, analytics, algorithmic trading, post-trade, market data, and trading and market-data APIs. Clients are institutional sell-side, retail and online brokers.
-
Investment management: portfolio management, OMS/EMS, FIX and connectivity, and an integrated market-data/OMS/PMS/CRM/wealth suite. Clients are investment managers, platforms, fund managers, private-client advisers, wealth managers and retail platforms.
-
Product comparisons: protection and retirement sourcing, quoting, comparison and application processing in the UK. The report also lists mortgage intermediary software. Note that the UK Mortgage Sales & Originations business was sold in August 2024; the residual mortgage comparison capability appears to sit within UK Sourcing.
Independent characterisation
| Revenue type | Share of 1H26 revenue (%) | Comment |
|---|---|---|
| Recurring (subscription, licence, data, usage) | 95 | $237.8m in 1H26, +3.4% constant currency [1H26R] |
| Non-recurring (projects, implementation, services) | 5 | ~$12.2m in 1H26 [DERIVED]. FY26 guidance assumes $7–8m lower non-recurring revenue than planned [1H26R]. |
Business model. Iress is a B2B, seat- and enterprise-licensed software vendor. Revenue is overwhelmingly recurring subscription and licence fees. Recurring revenue was $237.8m, or 95% of 1H26 Group revenue of $250.0m [1H26R]. Non-recurring revenue comes from implementation, project and professional-services fees. It was lower than expected in 2026, which drove the August 2026 revenue guidance downgrade [1H26R].
Revenue model mix.
Value-chain position. Iress is an application-layer software provider. It sits between market infrastructure (exchanges, data vendors, product manufacturers such as life insurers and annuity providers) and front-office users (financial advisers, paraplanners, brokers, dealers). Its key network assets are:
-
integrations into product providers through Xplan's "Iress Open" ecosystem of 100+ fintech and regtech integrations [AR25];
-
connectivity to 600+ brokers and venues through the Iress Global FIX Hub [AR25];
-
protection-insurer panels connected through UK Sourcing.
Customer types. Clients include:
-
Wealth: licensees and dealer groups, independent financial advisers, private banks, superannuation funds offering advice, and UK IFA networks.
-
Trading: retail, online and institutional brokers.
-
UK Sourcing: insurers and protection intermediaries.
End-markets. End-markets are Australian/NZ financial advice, UK financial advice and protection distribution, and equities trading and market data in Australia, South Africa and Canada.
Strategic character after the reset. Following eight divestments between 2023 and 2025, Iress is now a "pure" vertical software company. Its margin structure is improving: the Continuing Business Cash EBITDA margin rose from 17.0% in 1H25 to 24.5% in 1H26 [1H26R]. Top-line growth, however, remains low single digit: FY26 guidance is +1–2% in constant currency [1H26R].
Strategy
Stated strategy — key themes (FY25 Annual Report, FY25 and 1H26 releases)
The themes below are paraphrased, with short quotations only where the wording itself matters.
-
"Product-led execution, capital discipline and customer focus." This is the stated FY26 strategic frame [FY25R].
-
Strengthen / Evolve / Grow. This three-pillar framework was introduced at 1H26 [1H26R]:
-
Strengthen: the business efficiency program and structural margin improvement.
-
Evolve: product modernisation through the Thoughtworks partnership, AI embedded in engineering and product, the next evolution of Xplan, and data/insights in trading.
-
Grow: clearer client roadmaps, deeper enterprise relationships and commercial discipline to lift recurring revenue quality.
-
-
AI as moat, not threat. Management argues that deep client relationships and the complexity of regulated wealth and trading workflows form a defensive moat for safe, differentiated AI adoption. AI is to be embedded in software for user enablement, workflow, risk and compliance automation [AR25].
-
Durable, high-quality software business. The CEO's stated ambition is to achieve this through disciplined sequencing, execution and capital allocation [FY25R].
-
Client-centricity. NPS rose 15 points in FY25 (after +25 in FY24), and a Customer Experience Council has been established [AR25; MEDIA].
Strategic initiatives (last 24 months)
| Initiative | Announced | Scope / targets | Status | Source |
|---|---|---|---|---|
| Portfolio simplification | 2023–2025 | Exit non-core regulated-service and sub-scale businesses | Completed with the QuantHouse sale (Aug 2025) | AR25 |
| Debt refinancing | Jan 2025 | Replace $415m of facilities with $125m (2028/2030) on improved terms | Completed | AR25 |
| Dividend reinstatement and capital management plan | Feb 2025 | Target payout 50–70% of UPAT | FY25 payout 61%; 1H26 interim +27% | AR25; 1H26R |
| FY26 business efficiency program | 10 Nov 2025 | ~$30m annualised cost reduction by end-FY26; FY26 Cash EBITDA margin exit run-rate of 25% | $31.5m delivered by Jun 2026; further $6–9m in 2H26 | FY25R; 1H26R |
| Switch to Cash EBITDA headline metric | Feb 2026 | Adjusted EBITDA less capex; also used as an STI KPI | Implemented FY26 | AR25 |
| Thoughtworks partnership | 7 May 2026 | Multi-phase program across four priority areas: modernise core platforms, simplify architecture, AI-enabled growth in Wealth, technology advisory. Uses Thoughtworks' AI/works agentic development platform. | Mobilised in 1H26; delivery accelerating in 2H26 | ASX 7 May 2026; Thoughtworks release; 1H26R |
| Group CTO elevation | 14 May 2026 | Single Group CTO to drive AI-led modernisation | Appointed | Iress media release |
| Xplan AI and client portal | 2,026 | AI adviser workflow and productivity tools; refreshed client portal | In delivery | 1H26R |
| Xplan UK modernisation program | Feb 2026 | Focused modernisation and uplift of UK Xplan | Underway | MEDIA: Iress UK FY25 release |
| Challenger annuity integration | FY25 | Lifetime annuities embedded in Xplan | Targeted 2H26 | AR25 |
| Iress Partnership (UK) | 2,025 | Up to four deep-integration partners a year | PlannerPal and Moneyinfo onboarded | AR25 |
| Iress Data Insights | FY25 | Near-real-time insights and compliance reporting | Launched; being extended | AR25 |
| Cloud-native trading platform and buy-side EMS | FY25 | Modernised GTMD stack | Rolled out | AR25 |
| AI enablement of workforce | 2,025 | 4,000+ hours of AI training; AI immersion days with AWS, Databricks, Salesforce and Mantel Group | Ongoing | AR25 |
| ESG: GHG re-baselining | 2,025 | Re-baseline using 2025; reset targets in 2026 | Targets to be reset in 2026 | AR25 |
Management guidance and medium-term targets
| Metric (FY26) | Original guidance, Feb 2026, constant currency | Updated guidance, Aug 2026, constant currency | Updated, reported (FX-adjusted) |
|---|---|---|---|
| Revenue | $520–528m (+3–5%) | $509–515m (+1–2%) | $499–505m |
| Cash EBITDA | $116–123m (+15–23%) | $121–126m (+21–26%) | $119–124m |
| UPAT | $84–90m (+15–24%) | $84–88m (+15–21%) | $82–86m |
| Cash EBITDA margin exit run-rate | 25%+ | 25% | 25% |
Source: [FY25R; 1H26R].
Beyond FY26, no formal medium-term revenue target has been issued under the new CEO. Previous targets lapsed with the transformation. These include the FY21 "2025 strategy" goal of more than doubling NPAT [FY21R] and the FY23 target for FY24 exit run-rate EBITDA 20–30% above FY23 [MEDIA: Investor Daily]. Management has signalled that product investment will step up in 2H26, with the full efficiency benefit flowing into FY27 [1H26R].
Products & Services
Pricing models are not publicly disclosed product by product. Iress historically charges per-user or per-seat subscriptions, enterprise licences, market-data pass-through and transaction/usage fees. Management stated in February 2026 that it intends to align pricing more closely with client value [FY25R]. Launch years are given only where disclosed.
Wealth (APAC Wealth and UK Wealth)
| Product / offering | Description & capabilities | Target customer | Version / timing | Source |
|---|---|---|---|---|
| Xplan (Australia/NZ) — flagship | Integrated advice platform: CRM and client management, fact-find, strategy and modelling, statement-of-advice generation, portfolio data, research, business automation, compliance and obligations management, revenue and payments. Next evolution in 2026 adds AI-enabled adviser workflow and productivity tools and a refreshed client portal. | Licensees, dealer groups, independent advisers, super funds offering advice | AI-enabled release being delivered in 2026 | AR25; 1H26R |
| Xplan (UK) | UK version of the advice platform, supported by a "focused modernisation program" announced for 2026 | UK IFAs, networks, wealth managers | Modernisation program from 2026 | MEDIA: Iress UK FY25 release |
| Scaled / digital advice journeys | Digital advice workflows aimed at super funds and scaled-advice providers responding to Australian advice reforms | Super funds, institutions | Ongoing | AR25 |
| Iress Open | Open-architecture integration layer with 100+ fintech and regtech integrations into Xplan | Advice practices and their tech partners | Live | AR25 |
| Iress Partnership (UK) | Curated program for deep Xplan integrations; first partners PlannerPal (AI advice workflow) and Moneyinfo (client portal). Capped at four new partners a year. | UK advice firms | Launched 2025 | AR25 |
| Advisely | Community and content platform for advice professionals: 10,000+ Australian subscribers, 62,000+ people reached in 2025, Xplan Hub "ask me anything" sessions, FAAA-accredited Growth Masterclass | Australian advisers | Live; 2025 metrics | AR25 |
| Challenger lifetime annuity integration | Integration of Challenger lifetime annuity products directly into Xplan | Australian retirement advisers | Targeted for 2H26 launch | AR25 |
| Data-driven business analytics | Practice analytics and compliance reporting for advice businesses | Licensees | Live | AR25 |
UK Sourcing (within UK Wealth & Sourcing)
| Product / offering | Description & capabilities | Target customer | Version / timing | Source |
|---|---|---|---|---|
| The Exchange — flagship protection sourcing | Protection insurance quoting, comparison and application processing across insurer panels; new capabilities released in 2025, including automation features | Protection intermediaries, IFAs | Enhanced 2025 | MEDIA: Iress UK FY25 release |
| Retirement sourcing platforms | Annuity and retirement product comparison and quoting; AI enhancements added in 2025 | Retirement advisers | Enhanced 2025 | MEDIA: Iress UK FY25 release |
| Mortgage comparison / lender connectivity | Listed in AR25 under product comparisons (mortgage comparison, advice, lender connectivity). The MSO business was sold to Bain in Aug 2024. | Mortgage intermediaries, networks | — | AR25; 1H24R |
Global Trading & Market Data
| Product / offering | Description & capabilities | Target customer | Version / timing | Source |
|---|---|---|---|---|
| Cloud-native trading platform — flagship | New trading front-end and infrastructure; one of the unit's largest-ever investments | Retail and institutional brokers | Built and rolled out FY25 | AR25 |
| Order & execution management / smart order routing | Order management, execution, routing and algorithmic trading. Lineage traces to the Iress Order System (IOS), launched 1997. | Sell-side brokers | Ongoing | AR25; MEDIA |
| Iress Global FIX Hub | FIX connectivity network giving access to 600+ brokers and venues worldwide | Brokers, buy-side, venues | Expanded FY25 | AR25 |
| Buy-side EMS | Cloud-native execution management system for investment managers | Fund managers, buy-side traders | Implemented FY25 | AR25 |
| Iress Data Insights | Near-real-time business insight and compliance reporting; extended for trading clients | Brokers, wealth firms | Launched/extended FY25 | AR25; FY25 presentation |
| Market data & APIs | Real-time and reference market data, trading and market-data APIs. QuantHouse low-latency feeds continue under a five-year supply agreement with BAHA. | Brokers, platforms, fintechs | Ongoing | AR25; MEDIA |
| Portfolio management & analytics | Portfolio management and analytical tools for brokers and investment managers | Brokers, investment managers | Ongoing | AR25 |
| Post-trade solutions | Post-trade processing tools | Brokers | Ongoing | AR25 |
| South Africa (INET BFA heritage) | Market data, research and trading software for the South African market | South African brokers and asset managers | Ongoing | AR25; MEDIA |
| Canada operations | Trading and market-data (and historically wealth) software in Canada | Canadian brokers and dealers | Ongoing | FY25R |
Divested products (for reference)
| Former product | Exit | Source |
|---|---|---|
| Managed Fund Administration (OneVue MFA) | Sold to SS&C, 2023, $52m | MEDIA |
| Iress Platform (OneVue investment platform) | Sold to Praemium, Apr 2024 | ASX 15 Apr 2024 |
| Pulse (UK DFM portfolio management) | Sold to SecuritEase, Jun 2024 | FY24R |
| UK Mortgage Sales & Originations | Sold to Bain Capital, Aug 2024 | 1H24R |
| Superannuation administration (incl. Financial Synergy heritage) | Sold to Apex Group, May 2025 | AR25 |
| QuantHouse (low-latency market data) | Sold to BAHA, Aug 2025 | AR25 |
Financial Narrative
Comparability warning. Iress's metrics changed repeatedly over FY21–FY25:
-
FY21–FY22: "segment profit" and pro forma results.
-
FY23–FY25: "Underlying" then "Adjusted EBITDA".
-
FY26: "Cash EBITDA".
The group also divested about A$130m of annual revenue in 2024–2025. Statutory figures are the only fully consistent series.
Income statement
Sources and notes:
-
FY21 NPAT $73.8m [AGG: Stockopedia cash-flow statement, ARS source]. FY21 pro forma revenue was $600.2m and pro forma NPAT $58.9m [FY21R]. These are not statutory, so the statutory FY21 revenue cell is blank.
-
FY22 revenue was reported as $617.9m in [FY22R] and as $615.6m in the FY23 comparative [FY23R]. The difference reflects revenue-definition changes; the later comparative is used.
-
FY23 revenue was $625.7m [FY23R], restated to $626.1m in [FY24R].
-
FY22 underlying EBITDA of $146.4m comes from the FY23 comparative [MEDIA: ifa].
-
FY23 operating costs of $520.0m come from FY24 commentary [MEDIA: Professional Planner].
-
FY24–FY25 EBIT, interest, tax and NPAT are from [AR25]. Profit before tax is [DERIVED] as EBIT less net interest.
-
FY25 DPS of 24c is declared (11c interim + 13c final) [FY25R]. The AR25 OFR table shows "dividends per share 11.0c" for 2025, apparently on a paid-in-year basis. This discrepancy is flagged.
-
Gross profit is not reported, since Iress presents expenses by nature. Gross profit and gross margin are not publicly disclosed.
Margins and growth
Margins are [DERIVED] from 6.1, except the FY24/FY25 Adjusted EBITDA margins, which are reported [AR25]. The FY23 Adjusted EBITDA definition (which implies ~$106m) differs from "Underlying EBITDA" ($128.3m). The FY24 Adjusted EBITDA of $132.8m was +25.2% on the FY23 adjusted base [MEDIA: FY24 call summary].
Revenue CAGR FY22–FY25 (headline): −3.0% a year [DERIVED: (561.7/615.6)^(1/3) − 1]. This is distorted by divestments. The continuing business grew +6.5% reported and +4.5% constant currency in FY25 [FY25R; FY25 presentation].
Half-year bridge into FY26 (latest period)
Source: [1H26R]. Continuing growth rates are reported in constant currency: revenue +2.5%, Cash EBITDA +47.1%, margin +742bps. Recurring revenue was $237.8m (+3.4%).
Balance sheet
Sources and notes:
-
FY24–FY25 figures [AR25]. Total assets [DERIVED] as the sum of the three asset lines.
-
FY25 net debt of $66.3m is reported, down $45.3m [AR25]. FY24 net debt is therefore $111.6m [DERIVED]. FY23 net debt is [DERIVED] from the "net debt declined $209m over the year" statement [FY24 presentation].
-
Leverage ratios are reported [FY24R; FY25R]. Leverage was also 0.5x at 30 June 2026 [1H26R].
-
Facilities are $125m in total: $80m matures 2028 and $45m matures 2030 [AR25].
Cash flow
Sources and notes:
-
FY21–FY24 cash-flow lines [AGG: Stockopedia, sourced to annual reports].
-
Capitalised software [AR25]. FY25 dividends paid of $39.2m = $18.7m FY24 final + $20.5m FY25 interim [AR25].
-
FY25 operating cash flow is not captured.
-
Free cash flow is not reported on a consistent definition. Management states FY24 free cash flow "notably improved" [FY24 presentation]. From FY26 the Cash EBITDA metric (Adjusted EBITDA less capex) serves as the company's FCF proxy.
-
Buybacks: a $100m on-market buyback was being completed in 2021–2022 [FY21R; FY22R]. No buyback has occurred since 2023.
Ratios
All values are [DERIVED] from the tables above, except capitalised software / revenue, which is reported [AR25]. ROIC is a company STI metric ("Underlying ROIC") but its value is not publicly disclosed in the materials reviewed. ROIC was last disclosed at 9.4% statutory and 9.6% underlying for 1H22 [MEDIA: Motley Fool].
Commentary on trends, inflections and drivers
Phase 1 — Plateau (FY21–FY22). Revenue grew low single digits ($600.2m pro forma in FY21; ~$616m in FY22). Statutory NPAT fell from $73.8m to $52.7m as the cost base grew faster than revenue. Dividends were held at 46c a year, partly debt-funded alongside a $100m buyback. In hindsight this set up the balance-sheet stress of 2023.
Phase 2 — Crisis and reset (FY23). Cost inflation, especially salaries, and weaker trading volumes compressed earnings. FY23 statutory NPAT was a $(137.5)m loss after a $143.7m intangible impairment [FY23R; FY24 presentation]. Leverage reached 2.5x and dividends were suspended. The transformation launched at the April 2023 Investor Day combined cost reduction, pricing standardisation and non-core asset sales.
Phase 3 — Deleveraging (FY24–FY25). Five divestments raised the cash that cut net debt from ~$321m to $66m. Headcount fell from ~2,250 to 1,153 and operating costs dropped 18% across the two years ($520.0m to $425.5m). Adjusted EBITDA held at ~$133–136m despite losing ~$130m of revenue, so the margin rose from ~20% to 24.2%. Statutory NPAT in FY24 and FY25 was flattered by disposal gains of $63.3m and $30.9m respectively [AR25]. UPAT is therefore the better earnings guide: $63.4m rising to $73.9m.
Phase 4 — Margin harvesting and reinvestment (FY26). The efficiency program had delivered $31.5m of annualised savings by June 2026 against a ~$30m target, with $6–9m more expected in 2H26 [1H26R]. Margins jumped to 24.5% in 1H26. The binding constraint is now growth. Continuing revenue grew only 2.5% in constant currency in 1H26, and FY26 revenue guidance was cut from +3–5% to +1–2% [1H26R]. Capitalised development doubled in FY25 to 4.9% of revenue. Because Cash EBITDA deducts capex, management's headline measure now captures the cost of product investment that Adjusted EBITDA would have excluded.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue — headline/operating (AUD Mn) | — | 615.6 | 625.7 | 604.6 | 561.7 |
Revenue — Continuing Business (AUD Mn) | — | — | — | 473.4 | 504.3 |
Recurring revenue (AUD Mn) | — | — | 577.3 | 553.7 | — |
Operating costs (AUD Mn) | — | — | 520.0 | 471.8 | 425.5 |
Statutory EBITDA (AUD Mn) | — | 142.7 | 89.6 | — | — |
Underlying / Adjusted EBITDA (AUD Mn) | — | 146.4 | 128.3 | 132.8 | 136.2 |
Adjusted EBITDA — Continuing (AUD Mn) | — | — | — | 115.4 | 132.6 |
EBIT / profit before interest and tax (AUD Mn) | — | — | — | 106.7 | 116.5 |
Net interest and financing costs (AUD Mn) | — | — | 21.8 | 16.8 | 7.2 |
Income tax expense (AUD Mn) | — | — | — | 1.2 | 30.0 |
Profit before tax (AUD Mn) | — | — | — | 89.9 | 109.3 |
Statutory NPAT (AUD Mn) | 73.8 | 52.7 | -137.5 | 88.7 | 79.3 |
Underlying NPAT / UPAT (AUD Mn) | — | 72.3 | — | 63.4 | 73.9 |
Basic EPS (A cents) | — | 28.6 | -76.4 | 48.0 | 42.6 |
Underlying EPS (A cents) | — | — | — | 34.0 | 39.6 |
Dividends per share declared (A cents) | 46 | 46 | 0 | 10 | 24 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Underlying/Adjusted EBITDA margin (%) | 23.8 | 20.5 | 22.0 | 24.2 |
Continuing Adjusted EBITDA margin (%) | — | — | 24.4 | 26.3 |
EBIT margin (%) | — | — | 17.6 | 20.7 |
Statutory net margin (%) | 8.6 | -22.0 | 14.7 | 14.1 |
Headline revenue growth (%) | — | 1.6 | -3.4 | -7.1 |
Financial Analysis
| Metric | 1H25 Group | 1H26 Group | 1H25 Continuing | 1H26 Continuing |
|---|---|---|---|---|
Revenue (AUD Mn) | 299.5 | 250.0 | 249.4 | 250.0 |
Operating costs (AUD Mn) | 235.1 | 181.4 | 189.2 | 181.4 |
Cash EBITDA (AUD Mn) | 45.6 | 61.1 | 42.5 | 61.1 |
Cash EBITDA margin (%) | 15.2 | 24.5 | 17.0 | 24.5 |
UPAT (AUD Mn) | 32.9 | 38.8 | 31.2 | 38.8 |
Underlying EPS (A cents) | 17.6 | 20.8 | 16.7 | 20.8 |
Statutory NPAT (AUD Mn) | 17.3 | 32.0 | — | — |
Interim DPS (A cents) | 11.0 | 14.0 | — | — |
Balance Sheet and Financial Ratios (x)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Cash and cash equivalents (AUD Mn) | — | 66.2 | 55.3 |
Intangible assets incl. goodwill (AUD Mn) | — | 441.4 | 460.4 |
Other current and non-current assets (AUD Mn) | — | 222.6 | 153.7 |
Total assets (AUD Mn) | — | 730.2 | 669.4 |
Borrowings (AUD Mn) | — | 177.7 | 120.9 |
Other liabilities (AUD Mn) | — | 174.4 | 125.5 |
Net assets / equity (AUD Mn) | — | 378.1 | 423.0 |
Net debt (AUD Mn) | 320.6 | 111.6 | 66.3 |
Leverage ratio (x, net debt/EBITDA basis) | 2.5 | 1.0 | 0.5 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash from operating activities (AUD Mn) | 101 | 113 | 63.7 | 103 | — |
Capitalised software development (AUD Mn) | — | — | — | 14.0 | 27.3 |
Cash from investing activities (AUD Mn) | -34.6 | -32.0 | 25.8 | 130 | — |
Cash from financing activities (AUD Mn) | -64.4 | -77.9 | -108 | -213 | — |
Dividends paid (AUD Mn) | — | — | 0 | 0 | 39.2 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 |
|---|---|---|
ROE on closing equity, statutory (%) | 23.5 | 18.7 |
ROE on average equity, statutory (%) | — | 19.8 |
ROA on average assets (%) | — | 11.3 |
Debt / equity (x) | 0.47 | 0.29 |
Net debt / Adjusted EBITDA (x) | 0.84 | 0.49 |
Interest coverage, EBIT / net interest (x) | 6.4 | 16.2 |
Asset turnover, revenue / average assets (x) | — | 0.80 |
Capitalised software / revenue (%) | 2.3 | 4.9 |
Revenue by Region
| Region proxy | FY2024 | FY2025 |
|---|---|---|
United Kingdom — UK Wealth & Sourcing (AUD Mn) | 107.3 | 115.3 |
Australia/NZ — APAC Wealth (AUD Mn) | 130.5 | 133.7 |
Multi-region — GTMD: Australia, South Africa, Canada (AUD Mn) | 234.9 | 250.5 |
Region Proxy Details
| Region proxy | FY2025 |
|---|---|
UK revenue growth (%) | 7.5 |
Australia/NZ Wealth revenue growth (%) | 2.5 |
GTMD revenue growth (%) | 6.6 |
Geographic Revenue
| Currency pair | FY2025 | 1H2025 | 1H2026 |
|---|---|---|---|
AUD/GBP | 0.49 | 0.49 | 0.52 |
AUD/CAD | 0.90 | 0.89 | 0.97 |
AUD/ZAR | 11.55 | 11.70 | 11.51 |
Region Overview
| Region | Employees |
|---|---|
Asia-Pacific | 600 |
UK & Europe (incl. Tunisia) | 360 |
South Africa | 149 |
North America | 44 |
Remote | 51 |
Total | 1,153 |
Share Price History
| Date | Share price (AUD) | Context | Source |
|---|---|---|---|
8 Aug 2025 | 9.69 (intraday high) | Takeover talks confirmed | MEDIA: Reuters |
25 Nov 2025 | 9.68 | ASX price query | AGG: InvestSMART |
27 Jan 2026 | 8.58 | Pre-FY25 result | AGG: InvestSMART |
25 Feb 2026 | 6.77 at release; ~6.18 later | FY25 result; takeover off | AGG: InvestSMART |
7 May 2026 | 6.55 | Thoughtworks announcement | AGG: InvestSMART |
17 Aug 2026 | 7.91 at release; ~5.64 later | 1H26 result (−28.7%) | AGG: InvestSMART |
4 Sep 2026 | 5.67 | Latest verified quote | AGG: Investing.com |
Valuation Snapshot
| Multiple | Value | Basis | Source |
|---|---|---|---|
Market capitalisation (AUD Mn) | 1,059 | 5.67 × 186.8m | DERIVED |
Enterprise value (AUD Mn) | ~1125 | Market cap plus ~$66m net debt (FY25) | DERIVED |
P/E, FY25 statutory EPS (x) | 13.3 | 5.67 / 0.426 | DERIVED |
P/E, FY26E UPAT reported midpoint ($84m) (x) | 12.6 | ~45c EPS | DERIVED |
EV/Cash EBITDA, FY26E reported midpoint ($121.5m) (x) | 9.3 | — | DERIVED |
EV/Adjusted EBITDA, FY25 (x) | 8.3 | $136.2m | DERIVED |
EV/Sales, FY26E reported midpoint ($502m) (x) | 2.2 | — | DERIVED |
P/B, FY25 book $423.0m (x) | 2.5 | — | DERIVED |
Dividend yield, FY25 declared 24c (%) | 4.2 | — | DERIVED |
Dividend yield, last 12 months 27c (13c final + 14c interim) (%) | 4.8 | — | DERIVED |
Per-Share Data and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim DPS (A cents) | 16 | 16 | 0 | 0 | 11 |
Final DPS (A cents) | 30 | 30 | 0 | 10 | 13 |
Total DPS (A cents) | 46 | 46 | 0 | 10 | 24 |
Franking on final dividend (%) | 15 | 0 | 0 | 25 | 100 |
Facility Maturity Details
| Facility maturity | Amount (AUD Mn) |
|---|---|
2028 tranche | 80 |
2030 tranche | 45 |
Analyst Conclusions
Management guidance (FY26, updated 17 Aug 2026)
| Metric | Guidance |
|---|---|
| Revenue | +1–2% constant currency ($509–515m); reported $499–505m |
| Cash EBITDA | +21–26% constant currency ($121–126m); reported $119–124m |
| UPAT | +15–21% constant currency ($84–88m); reported $82–86m |
| Cash EBITDA margin exit run-rate | 25% |
Additional elements: a further $6–9m of annualised savings in 2H26, with the full benefit in FY27; higher product investment in 2H26 [1H26R].
Bull case
-
Margin compounding. A 25% Cash EBITDA exit run-rate on ~$500m of revenue, plus 2H26 savings flowing fully into FY27, could lift FY27 Cash EBITDA above FY26's ~$121–126m without revenue acceleration. On ~9x FY26 EV/Cash EBITDA, that rerates the equity.
-
Asset value and bid floor. Blackstone's withdrawn A$10.50 proposal and Thoma Bravo's engagement establish private-market appetite. The stock trades ~46% below that level with 0.5x leverage, supporting a renewed approach.
-
Product cycle. Thoughtworks-accelerated Xplan AI tools, the Challenger annuity integration (2H26), the cloud-native trading platform and the UK Xplan modernisation provide multiple catalysts for pricing power and retention in a 95%-recurring revenue base.
Bear case
-
Growth stall. Continuing revenue grew just 2.5% in constant currency in 1H26 and FY26 guidance was cut to +1–2%. Margin gains are cost-driven, and cost-out has a natural limit.
-
AI disruption of the moat. Agentic AI may lower the cost of building advice workflows, enabling platforms (HUB24, Netwealth) and AI-native challengers to erode Xplan. The ~37% software-sector de-rating suggests the market is discounting this.
-
Execution and leadership risk. Iress has had three CEOs and an interim in four years. Outsourced modernisation, rising 2H26 investment and a 53% engagement score raise delivery risk. Failed LTI hurdles reflect a history of overpromising.
Key catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | What to watch |
|---|---|---|
| FY26 result | ~Feb 2027 | Delivery of the 25% exit run-rate; FY27 guidance; revenue growth reacceleration |
| Challenger annuity integration launch | 2H26 | Adoption by Australian advisers |
| AI-enabled Xplan and client portal releases | 2H26–1H27 | Pricing uplift and retention evidence |
| Non-recurring revenue trend | Ongoing | Signals of client project appetite |
| Capital management | FY26 result | Possible buyback given 0.5x leverage |
| Register changes and possible M&A interest | Ongoing | Substantial-holder accumulation; unsolicited approaches |
| New non-executive director appointment | FY26–FY27 | Board renewal toward the 40% female target |
| FX | Ongoing | AUD versus GBP, CAD and ZAR translation effects |
| 2026 GHG target reset | 2026–2027 | New science-based targets on the 2025 base year |
Analyst verdict
Iress enters late 2026 as a different company from the over-levered, sprawling group of 2023. Eight divestments, a 50% headcount reduction and a $125m refinanced debt stack have produced a focused, two-franchise vertical software business. It carries 95% recurring revenue, 0.5x leverage and a Cash EBITDA margin that has jumped above 24% within a year. On reported numbers, the turnaround is real: UPAT rose 18% in 1H26, the dividend is fully franked and climbing, and FY26 Cash EBITDA guidance was raised even as revenue guidance fell.
The market's 29% punishment on 17 August 2026 nonetheless reflects a legitimate concern. The equity story has shifted from "self-help" to "growth", and the growth evidence is thin. Constant-currency continuing revenue growth of 2.5%, softening non-recurring revenue and an AI-anxious software tape leave little room for error. Value creation now depends on Andrew Russell converting Xplan's entrenched incumbency into pricing power and new revenue through the Thoughtworks-led modernisation. That is a credible but unproven proposition, and Iress's recent history of leadership turnover and forfeited incentive hurdles warrants scepticism.
At ~A$5.67, the stock trades on roughly 12–13x FY26 UPAT, ~9x FY26 EV/Cash EBITDA and a ~4.8% trailing yield. Those multiples largely price the business as an ex-growth cash generator. The downside is cushioned by cash generation, a clean balance sheet and demonstrated private-equity appetite at materially higher prices. The upside requires only modest revenue reacceleration on a margin base that should step up again in FY27.
Overall assessment: constructive, with high execution dependency. The decisive monitorables are the February 2027 FY26 result, specifically confirmation of the 25% exit run-rate and an FY27 outlook showing revenue growth above 3% in constant currency, plus any sign of capital-management deployment or renewed strategic interest.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | In role since | Prior roles / background | Education |
|---|---|---|---|---|
Andrew Russell | Group CEO & Managing Director | 17 Nov 2025 | Group CEO & MD, Bravura Solutions (Jul 2023–Apr 2025); CEO & MD, Class Limited (sold to HUB24 in 2022); founding EGM of REA Group's financial services division; senior roles at Mortgage Choice and Virgin Money Australia | BEc, MBA, GAICD [AR25] |
Cameron Williamson | Group Chief Financial Officer | — | Not captured in the materials reviewed | — |
Geoff Rogers | CEO — Global Trading & Market Data | KMP full year FY25 | Interim Group CEO, 5 Sep–16 Nov 2025 | — |
Alistair Morgan | CEO — UK | KMP from 11 Aug 2025 (led the UK business from 2024) | Led the UK turnaround (UK EBITDA +170%+ in FY24) | — |
Sam Wall | CEO — APAC Wealth | Acting from Feb 2026; permanent from 14 May 2026 | Formerly CEO of Iress Superannuation (joined Sep 2024; transferred to Apex at sale, then returned) | — |
Darryl Campbell-Blackwell | Group Chief Technology Officer | 14 May 2026 | Former UK CTO; ~16 years at Iress, starting as a technical architect; UK-based | — |
Naomi Dawson | Company Secretary | Mar 2024 | Company Secretary & Senior Legal Counsel, PEXA (9+ years) | BComm, LLB(Hons), LLM, GDipAppCorpGov, FGIA [AR25] |
Executive Leadership Team — Marcus Price
| Name | Former role | Departure | Context |
|---|---|---|---|
Marcus Price | Group CEO & MD | Stepped down 4 Sep 2025 (CEO since Oct 2022) | Succession process run during takeover talks [AR25] |
Harry Mitchell | Deputy Group CEO | Ceased 11 Aug 2025 | Role abolished after leadership review; had overseen the UK turnaround, APAC Wealth reset and super divestment [AR25; MEDIA] |
Kelli Willmer | CEO APAC Wealth | Ceased as KMP 13 Feb 2026 | Held the role ~2.5 years [AR25; MEDIA] |
Governance Overview
| Element | Detail | Source |
|---|---|---|
CEO STI opportunity | 120% target / 180% maximum of fixed salary. Other executive KMP: 60% target / 90% maximum. | AR25 |
STI company measures (FY25) | Adjusted Group EBITDA, underlying ROIC, Net Promoter Score, revenue. Board applied a risk modifier that reduced FY25 outcomes. | AR25 |
LTI (FY25 grant) | Share Appreciation Rights: 50% tested on absolute TSR (6–12% a year vesting range), 50% on EPS CAGR (5–10%). Starting VWAP $7.884. | AR25 |
Former CEO LTI face value | $1,275,000 (150% of fixed salary, implying ~$850k fixed) | AR25; DERIVED |
Andrew Russell sign-on | 134,471 performance rights compensating ~$1.2m of forfeited incentives; issued 12 Mar 2026, valued at $938,607 | AR25; AGG: Motley Fool director dealings |
2022 LTI outcome | Grant 1 forfeited in full (absolute TSR gate not met). Grant 2 (Mar 2026) expected to be forfeited. | AR25 |
Minimum shareholding | CEO 150% of base salary within five years (by Dec 2030); other executive KMP 75% | AR25 |
FY25 fixed pay changes | Price +9.8%; Mitchell +4.9%; Williamson +3.5%; Willmer +10.9%; Rogers one-off 9.1% acting allowance; Morgan nil | AR25 |
Board of Directors
| Director | Role | Appointed | Independence | Committee roles | Other key roles / background |
|---|---|---|---|---|---|
Roger Sharp | Chair | Director Feb 2021; Chair May 2021 | Independent | Attends ARC and PPC | Chair, Web Travel Group (ASX:WEB); Chair, North Ridge Partners; ex-Global Head of Technology and CEO Asia Pacific Securities, ABN AMRO |
Andrew Russell | Group CEO & MD | Nov 2025 | Executive | — | See 9.1 |
Trudy Vonhoff | Non-executive director | Feb 2020 | Independent | Chair, Audit & Risk Committee (since May 2021); PPC member | Director, Credit Corp (ASX:CCP) and Cuscal (ASX:CCL); ex-Westpac and AMP executive |
Michael Dwyer AM | Non-executive director | Feb 2020 | Independent | ARC and PPC member | Chair, TCorp (NSW Treasury Corporation); ex-CEO First State Super (14 years) |
Anthony Glenning | Non-executive director | Oct 2022 | Independent | — | Director, Pro Medicus (ASX:PME) and Austco Healthcare; founder of Tonic Systems (sold to Google, 2007) |
Susan Forrester AM | Non-executive director | Oct 2024 | Independent | Chair, People & Performance Committee (from 1 Jan 2025) | Chair, Jumbo Interactive (ASX:JIN); Takeovers Panel member; AICD director |
Robert Mactier | Non-executive director | Oct 2024 | Independent | ARC member | Chair, Nuix (ASX:NXL); consultant to UBS Australia |
Major Shareholders
| Holder | Event | Date | Source |
|---|---|---|---|
Perpetual Limited | Became substantial holder | 13 Aug 2026 (notice 17 Aug) | MEDIA: Webull ASX filing mirror |
Perpetual Limited | Ceased to be substantial holder | 31 Aug 2026 (notice 2 Sep) | MEDIA: FilingReader; Perpetual |
Norges Bank / associated entity | Change in substantial holding | 18 Aug 2026 (previous notice 20 Mar 2026) | MEDIA: Webull ASX filing mirror |
State Street Corporation | Change in substantial holding | — | MEDIA: TipRanks |
Morgan Stanley & associates | Became substantial holder | 28 Aug 2026 | MEDIA: Webull ASX filing mirror |
Unnamed holders | Multiple become/cease notices (Dec 2025, Jan 2026, Mar 2026, Jul 2026), consistent with event-driven and hedge-fund trading around the takeover process | Various | AGG: InvestSMART announcement list |
Directors' Shareholdings
| Director | Date | Shares | Value (AUD) |
|---|---|---|---|
Michael Dwyer | 10 Mar 2026 | 5,370 | 40,167 |
Susan Forrester | 5 and 10 Mar 2026 | 1,996 and 3,283 | 14,830 and 24,720 |
Roger Sharp | 20 Aug 2026 | 16,265 | 98,889 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning vs Iress | Notes |
|---|---|---|---|
APAC Wealth (advice software) | Midwinter (AdviceOS) | Main Australian advice-software challenger | — |
APAC Wealth | Morningstar AdviserLogic | Lower-cost, cloud-native advice software for small practices | Part of Morningstar Inc. |
APAC Wealth | Platform-embedded advice tooling (HUB24 incl. Class and myprosperity; Netwealth) | Platforms bundling practice and advice tools could disintermediate Xplan | HUB24 acquired Class in 2022 (the CEO's former company) |
APAC Wealth | In-house and digital advice builds at super funds and banks | Substitution risk in scaled advice | — |
UK Wealth | Intelliflo | Leading UK cloud adviser back-office (intelliflo office) | — |
UK Wealth | Time4Advice (Curo); Plannr; Dynamic Planner | Challenger CRM and planning tools | Plannr launched to challenge Intelliflo, Iress and Time4Advice [MEDIA: Financial Planning Today] |
UK Sourcing | Other protection and retirement comparison portals | Competition for the intermediary quote-and-apply workflow | — |
GTMD (terminals and data) | Bloomberg; LSEG (Workspace/Refinitiv); FactSet | Global data and terminal incumbents | Far larger scale |
GTMD (OMS/EMS, FIX) | ION Group (incl. Fidessa); SS&C Eze; FlexTrade; Virtu (Triton) | Global trading-workflow vendors | Compete for institutional sell-side and buy-side |
GTMD (Australia retail broker tech) | Broker in-house builds; global white-label providers | Retail broker platform competition | — |
GTMD (South Africa) | Local and global data vendors | INET-heritage incumbency | — |
Peer Comparison FY2025
| Company | Latest FY revenue | Revenue growth | EBITDA margin | R&D intensity | Source |
|---|---|---|---|---|---|
Iress (FY25) | A$561.7m headline; A$504.3m continuing | -7.1% headline; +6.5% continuing | 24.2% headline; 26.3% continuing (Adjusted) | 4.9% capitalised software / revenue | AR25 |
Recent Developments
The next scheduled result is FY26 (expected February 2027). Aggregator dates of 5 Nov or 16 Nov 2026 appear to be placeholders inconsistent with Iress's half-yearly reporting cycle.



